Skip to main content

zoledronic acid

Generic: ZOLEDRONIC ACID·Brand: RECLAST, Reclast, ZOLEDRONIC, ZOLEDRONIC ACID, ZOMETA

zoledronic acid: 3 clinical trials tracked.

zoledronic acid evidence translation

What we can confirm

3 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about zoledronic acid, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Clinical Trial Registry Records (3)

Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia: An Exploratory Study

NCT07471516Registry updated 2026-03-13·Phase 1/Phase 2
Recruiting

Primary endpoint: Change in Hemoglobin Level From Baseline

Interventionalopen2 targetStarted 2026-02Completion 2027-081 site · ChinaInstitute of Hematology & Blood Diseases Hospital, China

A Phase Ib/II Trial of Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

NCT06374459Registry updated 2026-04-20·Phase 1/Phase 2
Recruiting

Primary endpoint: Number of participants with adverse events (Phase Ib only)

InterventionalRandomizedopen152 targetStarted 2025-01Completion 2032-053 sites · United StatesWashington University School of Medicine

Solitary Plasmacytoma of Bone: Randomized Phase III Trial to Evaluate Treatment With Adjuvant Systemic Treatment and Zoledronic Acid Versus Zoledronic Acid After Definite Radiation Therapy

NCT02516423Registry updated 2026-06-30·Phase 3
Terminated

Primary endpoint: Symptomatic Myeloma Progression Free-survival (PFS) Rate

InterventionalRandomizedopen11 targetStarted 2016-11Completion 2025-0950 sites · United StatesAlliance for Clinical Trials in Oncology